Source: HIT Consultant Media

OSE Immunotherapeutics: OSE Immunotherapeutics & Scienta Lab Partner to Advance AI-Driven Drug Discovery

What You Should Know: - OSE Immunotherapeutics SA, a biotechnology company focused on developing innovative immunotherapies, and Scienta Lab, a pioneer in AI-driven precision immunology is forming a strategic collaboration to leverage the power of artificial intelligence (AI) in the fight against inflammatory diseases. - The partnership will harness Scienta Lab's advanced AI platform, EVA, ... Read More

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Nicolas Poirier's photo - CEO of OSE Immunotherapeutics

CEO

Nicolas Poirier

CEO Approval Rating

87/100

Read more